Society for Immunotherapy of Cancer (SITC) shared a post on LinkedIn:
“Don’t miss the first webinar in our Deep Dive Series, happening June 30th! Explore the mechanisms and clinical development of PD-1/VEGF bispecifics with expert faculty examining emerging biology, engineering strategies, and the latest clinical data.
Other articles about Immunotherapy on OncoDaily.